Charcterization of two direct fibrinogenolytic activities and of one proteolytic inhibitor activity in the human prostate.
D000135:Acid Phosphatase / Q000032:analysis; D002850:Chromatography, Gel; D004791:Enzyme Inhibitors / Q000302:isolation & purification; D000939:Epitopes; D004950:Esterases / Q000032:analysis; D005340:Fibrinogen / Q000037:antagonists & inhibitors* / Q000378:metabolism; D005341:Fibrinolysin / Q000037:antagonists & inhibitors; D006801:Humans; D008297:Male; D010447:Peptide Hydrolases / Q000302:isolation & purification / Q000494:pharmacology; D011467:Prostate / Q000201:enzymology*; D011470:Prostatic Hyperplasia / Q000201:enzymology*; D011480:Protease Inhibitors; D014020:Tissue Extracts / Q000032:analysis; D014361:Trypsin Inhibitors / Q000494:pharmacology
D004791:Enzyme Inhibitors; D000939:Epitopes; D011480:Protease Inhibitors; D014020:Tissue Extracts; D014361:Trypsin Inhibitors; D005340:Fibrinogen; D004950:Esterases; D000135:Acid Phosphatase; D010447:Peptide Hydrolases; D005341:Fibrinolysin